Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Quality of Life and Social Functionality With Escitalopram in the Treatment of Major Depressive Disorder With Anxiety Symptom

NCT01870843 is registered in ClinicalTrials.gov with Xian-Janssen Pharmaceutical Ltd. as lead sponsor.

NCT NCT01870843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01870843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Quality of Life and Social Functionality With Escitalopram in the Treatment of Major Depressive Disorder With Anxiety Symptom
Lead sponsor
Xian-Janssen Pharmaceutical Ltd.
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2014
Completion date
May 31, 2015
Enrollment
261 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major